CVS Faces Potential Activist Pressure Following Share Price Drop
Written by Ohris M. Greyoon, Blockchain & Crypto Expert
Activist Pressure on CVS: Glenview Capital Management is set to meet with CVS executives amid investor concerns, as CVS shares have dropped 24% year-to-date and the company faces financial challenges, particularly in its Medicare business.
Market Response and Outlook: Despite recent struggles, CVS stock showed signs of recovery with a slight increase in pre-market trading, and analysts maintain a cautiously optimistic outlook with recommendations leaning towards "Buy" and a high price target of $91.12.
About the author
Ohris M. Greyoon
Ohris M. Greyoon holds a Master’s in Computer Science from MIT and has 10 years of experience in blockchain technology and cryptocurrency markets. A pioneer in decentralized finance (DeFi) analysis, he leads Intellectia’s Crypto News, offering cutting-edge insights into digital assets.
